Related Experiment Video
Updated: Jun 6, 2026

Transmembrane Domain Oligomerization Propensity determined by ToxR Assay
Published on: May 26, 2011
Role of transmembrane segment 5 and extracellular loop 3 in the homodimerization of human ABCC1
Youyun Yang1, Wei Mo, Jian-Ting Zhang
1Department of Pharmacology and Toxicology and IU Simon Cancer Center, Indiana University School of Medicine, Indianapolis, Indiana 46202, United States.
Abstract:
Resistance to multiple anticancer agents is a major obstacle in the successful treatment of cancers. Overexpression of some ATP-binding cassette (ABC) membrane transporters such as ABCC1 has been shown to be a major contributor of multidrug resistance (MDR) in both laboratory cell line models and the clinical setting. ABCC1 has been thought to function as a homodimer with a putative dimerization domain located in the first 281 amino acid residues, including MSD0 and L0 domains. In this study, we further mapped in detail the dimerization site and placed it in TM5 and ECL3 in MSD0 using co-expression and co-immunoprecipitation of a series of deletion constructs. TM5 and ECL3 in one subunit appear to interact with TM5 and ECL3 in the opposing subunit in a sequence-independent manner, but their physical location together with the hydrophobicity of TM5 and the length of ECL3 appears to be important contributors to the dimerization ability of ABCC1.
Insights
Multidrug resistance (MDR) in cancer is often caused by ATP-binding cassette (ABC) transporters like ABCC1. This study identifies specific transmembrane domains (TM5 and ECL3) within ABCC1
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Multidrug resistance (MDR) is a significant challenge in cancer therapy.
- Overexpression of ATP-binding cassette (ABC) transporters, particularly ABCC1, contributes significantly to MDR.
- ABCC1 is believed to function as a homodimer, with a dimerization domain previously localized to the N-terminal region.
Purpose of the Study:
- To precisely map the dimerization site of the ABCC1 transporter.
- To investigate the specific domains and regions involved in ABCC1 homodimerization.
Main Methods:
- Utilized co-expression and co-immunoprecipitation techniques.
- Employed a series of deletion constructs to systematically analyze ABCC1 domains.
- Focused on the membrane-spanning domain 0 (MSD0) and its components.
Main Results:
- The dimerization site of ABCC1 was further refined to transmembrane helix 5 (TM5) and extracellular loop 3 (ECL3) within MSD0.
- Interaction between TM5 and ECL3 of one ABCC1 subunit with the corresponding regions of an opposing subunit was observed.
- Dimerization appears sequence-independent but relies on the physical location, hydrophobicity of TM5, and length of ECL3.
Conclusions:
- TM5 and ECL3 in MSD0 are critical for ABCC1 homodimerization.
- Understanding these interactions may offer novel strategies to overcome ABCC1-mediated MDR in cancer treatment.
Related Concept Videos
Structure of Cadherins
ABC Transporters: Exporter
Multi-pass Transmembrane Proteins and β-barrels
α-Helix containing multi-pass transmembrane proteins
Multi-pass transmembrane proteins such as G-protein-linked receptors (GPCRs) and...
Membrane Asymmetry Regulating Transporters
Flippase
Eukaryotic flippases are type-IV P-type ATPases or P4-ATPases belonging to P-type ATPase family proteins that are membrane-bound pumps involved in the ATP-mediated transport of ions and molecules across the membrane. Flippases flip specific phospholipids from the outer to the inner leaflet of a membrane. All P4-ATPases have one...
Insertion of Multi-pass Transmembrane Proteins in the RER
The multipass transmembrane proteins are the type IV integral membrane proteins with multiple topogenic sequences determining their spatial arrangement in the ER membrane. Nearly all multipass proteins lack a cleavable signal sequence and use...
Single-pass Transmembrane Proteins

